Skip to main content

Cavalie Fanny's Form 4 filing

Foghorn Therapeutics Inc.FHTX · filed Mar 12, 2024

Accession no.
0001562180-24-002591
Filed
Mar 12, 2024
Trade date
Mar 11, 2024
Filing delay
1 day
Rule 10b5-1 plan
Not checked

This filing lists 1 non-derivative transaction. Open-market sales total $72.2K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Cavalie FannyCIK 0001913484Officer (Chief Strategy/Bus Ops Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 11, 2024Common StockSSaleDisposed−11,000$6.56F1−$72,16075,992Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

This transaction was executed in multiple trades at prices ranging from $6.50 USD to $6.83 USD; the price reported above reflects the weighted average sale price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)